4.690SEK+4.22%Mkt Cap: 99.26M SEKP/E: —Last update: 2026-06-01
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample prepara…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap99.26M SEK
Enterprise Value82.34M SEK
Revenue (TTM)10.05M SEK
Gross Profit6.74M SEK
Net Income (TTM)-12.15M SEK
Revenue/Share0.4900 SEK
Last Price4.690 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.63
PEG—
EV/EBITDA-7.85
EV/Revenue8.19
P/S9.47
P/B5.84
EPS (TTM)-0.48
EPS (Forward)-0.80
52W Range
2.03090% of range5.000
52W High5.000 SEK
52W Low2.030 SEK
Profitability
Gross Margin98.38%
Oper. Margin-135.53%
EBITDA Margin-104.35%
Profit Margin-177.34%
ROE-74.55%
ROA-67.92%
Growth
Revenue Growth-14.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.78M SEK
CapEx (TTM)488.00K SEK
FCF Margin-48.20%
FCF Yield-4.88%
Net Debt-14.57M SEK
Net Debt/EBITDA1.39
Balance Sheet
Debt/Equity—
Current Ratio1.69
Quick Ratio1.34
Book Value/Sh0.7700 SEK
Cash/Share0.6770 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Target (Mean)11.00 SEK
Target Range11.00 SEK – 11.00 SEK
# Analysts1
Ownership
Shares Out.21.16M
Float16.86M
Insiders40.48%
Institutions2.34%
Technical
SMA 503.646 (+28.6%)
SMA 2003.033 (+54.6%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)43.21K
Avg Vol (10d)46.83K
Technical Indicators
RSI (14)59.2
MACD0.2726
MACD Signal0.3345
MACD Hist.-0.0619
BB Upper5.212 SEK
BB Middle4.343 SEK
BB Lower3.474 SEK
BB Width40.01%
ATR (14)0.4005 SEK
Vol Ratio (20d)0.85x